Company location
Tokyo, Japan
TAKEDA PHARMACEUTICAL CO LTD has filed 676 SEC EDGAR filings since 05 Mar 2007

SEC filing history

Showing 176-200 of 662 matching filings.

Per page
25
Current page
8
13F-HR File 028-24938

13F-HR filing

Filing date
13 Feb 2025
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-24938

13F-HR filing

Filing date
13 Feb 2025
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
13 Feb 2025
Reporting date
13 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-24938

13F-HR filing

Filing date
12 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
30 Jan 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
18 Dec 2024
Reporting date
18 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
13 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
02 Dec 2024
Reporting date
02 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
31 Oct 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
31 Oct 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
31 Oct 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
26 Sep 2024
Reporting date
26 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
22 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
31 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38757

6-K

Filing date
31 Jul 2024
Reporting date
31 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38757

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .